|

CORCEPT THERAPEUTICS INC (CORT)

US2183521028 - Common Stock

25.97  +0.5 (+1.96%)

After market: 25.97 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates.

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
353.9M
15.46%		366M
3.42%		401.9M
9.81%		474.18M
17.98%
EBITDA
YoY % growth
128.7M
14.60%		125.6M
-2.41%		113.4M
-9.71%		103.43M
-8.79%
EBIT
YoY % growth
128.2M
14.87%		124.5M
-2.89%		112.6M
-9.56%		101.23M
-10.10%
Operating Margin
36.22%34.02%28.02%21.35%
EPS
YoY % growth
0.85
8.97%		0.89
4.71%		0.88
-1.12%		0.82
-6.69%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		0.26
85.79%
Revenue
Q2Q % growth		130.38M
26.46%
EBITDA
Q2Q % growth		26.52MN/AN/AN/AN/A
EBIT
Q2Q % growth		32.636M
45.05%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSuprise
Q3 2023
Q2Q % growth		 0.28
-6.67%		0.220.0625.73%
Q2 2023
Q2Q % growth		 0.25
4.17%		0.150.1063.40%
Q1 2023
Q2Q % growth		 0.14
-30.00%		0.20-0.06-29.00%
Q4 2022
Q2Q % growth		 0.14
-46.15%		0.23-0.09-39.00%
Q3 2022
Q2Q % growth		 0.30
25.00%		0.230.0730.72%
Q2 2022
Q2Q % growth		 0.24
14.29%		0.240.000.13%
Q1 2022
Q2Q % growth		 0.20
11.11%		0.24-0.04-17.61%
Q4 2021
Q2Q % growth		 0.26
30.00%		0.220.0418.56%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSuprise
Q3 2023
Q2Q % growth		 123.6M
21.53%		122.07M1.53M1.25%
Q2 2023
Q2Q % growth		 117.7M
13.83%		111.88M5.82M5.20%
Q1 2023
Q2Q % growth		 105.7M
12.81%		106.97M-1.27M-1.19%
Q4 2022
Q2Q % growth		 103.1M
4.35%		107.18M-4.08M-3.81%
Q3 2022
Q2Q % growth		 101.7M
5.83%		109.74M-8.04M-7.33%
Q2 2022
Q2Q % growth		 103.4M
12.88%		103.02M380K0.37%
Q1 2022
Q2Q % growth		 93.7M
18.01%		100.86M-7.16M-7.10%
Q4 2021
Q2Q % growth		 98.8M
15.29%		102.58M-3.78M-3.68%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS21.43% 24.39% 0% 1.26%
Revenue4.56% 4.87% 0% 0.11%